Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis and ribosome footprints in engineered chromosome 3 and chromosome 8 isogenic aneuploidy cell model.

ABSTRACT: We analyzed two isogenic aneuploidy models. The first model is the chromosome 3 isogenic aneuploidy model, which includes three cell types: chromosome 3 WT, 3q gain, and 3p loss. By comparing with chromosome3 WT, we evaluated the overall transcript expression changes in 3q gain and 3p loss cells. Additionally, by comparing with chromosome3 WT, we assessed the changes in ribosome-protected fragments in 3p loss cells. The second model is the chromosome 8 isogenic aneuploidy model, which includes two cell types: chromosome 8 WT and 8p loss. By comparing with chromosome 8 WT, we evaluated the overall transcript expression changes in 8p loss cells.

ORGANISM(S): Homo sapiens

PROVIDER: GSE267065 | GEO | 2025/11/13

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Divergent proteome tolerance against gain and loss of chromosome arms

Project description:How aneuploid cells tolerate chromosome arm gains or losses remains an open question. Using an isogenic human lung cell model with either 3p loss or 3q gain, combined with quantitative mass spectrometry and isotopic labeling, we reveal distinct proteostasis mechanisms for gain- and loss-type aneuploidy. Surprisingly, while compensation for 3q gain is primarily driven by increased degradation of excess protein complex subunits, 3p loss is neither counteracted by global protein degradation nor selectively reduced degradation, but rather by relatively upregulated protein synthesis to maintain protein complex stoichiometry. Additionally, proteins encoded on 3p exhibit increased thermal stability in loss-type aneuploidy, potentially via their interactions with other proteins from euploid chromosomes. Together, our findings uncover distinct proteomic buffering strategies that enable cells to tolerate either excessive or deficient single-arm aneuploidy.

2025-10-06 | PXD062437 | Pride

aCGH was used to identify the overall genomic imbalances of SCC of the vulva in 14 patients

Project description:The imbalances scored by arrayCGH mapped to different chromosomes with losses being more common than gains. Frequent losses of large chromosomal segments were scored from 3p and 8p whereas same-sized gains were frequent from 3q and 8q. This is the first study of vulvar tumors using arrayCGH, and some frequent imbalances could be defined precisely.

2013-01-16 | GSE38229 | GEO

aCGH was used to identify the overall genomic imbalances of SCC of the vulva in 14 patients

2013-01-16 | E-GEOD-38229 | biostudies-arrayexpress

Uveal melanoma cell lines are representative for their tumour, except cell lines Mel285 and Mel290: the odd two out

Project description:Purpose: In uveal melanoma (UM) research, several cell lines are used in preclinical studies. Because Mel285 and Mel290 do not harbour typical GNAQ or GNA11 hotspot mutations, we aimed at better classifying them and understanding if we could find genetic causes to explain their protein and mRNA expression profiles. Methods: We studied protein and mRNA expression in 14 UM cell lines and determined the presence of Single Nucleotide Variants and small Insertions and Deletions with next generation sequencing and copy number alterations (CNAs) with a single nucleotide polymorphism array. The lists of differentially expressed proteins and genes were merged, and shared lists were created, keeping only the terms with concordant mRNA and protein expression. Enrichment analysis and Gene Set Enrichment Analysis were performed on the shared lists. Results: Mel285 and Mel290 are distinct from the GNA-mutated cell lines and have downregulation of melanosome-related markers. Mel285 and Mel290 lack typical UM mutations but harbour putatively-deleterious variants in four genes each (Mel285: CTNNB1, PPP1R10, LIMCH1, APC; Mel290: ARID1A, PPP1R10, SPG11, RNF43). The upregulated terms in Mel285 and Mel290 did not point to a convincing alternative origin. Mel285 has several CNAs, among which loss of 1p, 3p, partial 3q, 6 and partial 8p, while Mel290 shows 1p loss and chromosome 6 loss. Conclusion: While Mel285 and Mel290 have some CNAs that resemble those in UM, multi-omics analyses show that they belong to a separate group compared to the other analysed UM cell lines. Therefore, they may not be representative models to test potential therapeutic targets for UM.

2024-07-16 | PXD051055 | Pride

8p Loss of Heterozygosity triggers metastasis and drug resistance

Project description:Chromosome arm deletions are frequently observed in human cancers. Such large-scale aberrations may trigger phenotypes distinct from those that arise by loss of single genes. Using TALEN-based genomic engineering, we generated cell models with targeted 8p loss-of-heterozygosity (LOH) that mimics an 8p deletion commonly found in breast cancer patients. 8p LOH triggered up-regulation of the mevalonate pathway. The alterations in lipid metabolism led to increased metastatic potential and drug resistance of 8p-deleted cells that are in agreement with poorer survival rates of breast cancer patients harbouting 8p LOH. Our findings also suggest novel therapeutic strategies for treatment of 8p LOH tumors. RNASeq Analysis of two Wt 8p Cell clones vs two 8p LOH cell clones generated via TALEN Approach

2015-05-21 | E-GEOD-68042 | biostudies-arrayexpress

A synthetic lethal strategy to target chromosome 8p deleted cancers

Project description:This project aimed to identify a specific target for chromosome 8p deletions. Using large-scale functional-genomic screening data of over 527 well-characterized cancer cell lines. We were able to identify the dependency of SLC25A28 (Mitoferrin-2, MFRN2), a mitochondrial iron transporter, in chromosome 8p deleted cancer cell lines. Interestingly, we found that SLC25A37 (Mitoferrin-1, MFRN1), the paralog of MFRN2, resides on chromosome 8p and is frequently deleted in liver cancer. We found a strong correlation between the cellular dependency on MFRN2 and the MFRN1 expression levels, possibly explaining why MFRN2 is a synthetic lethal target for 8p deletions. Our study discovered MFRN2 as a target for a therapeutic strategy in chromosome 8p deleted cancer specimens. Further, it revealed MFRN1 as a biomarker that predicts the response to MFRN2-directed therapy.

2024-06-03 | PXD044780 | Pride

8p Loss of Heterozygosity triggers metastasis and drug resistance

2015-05-21 | GSE68042 | GEO

Transcriptome analysis and ribosome footprints in engineered chromosome 3 and chromosome 8 isogenic aneuploidy cell model.

Project description:Transcriptome analysis and ribosome footprints in engineered chromosome 3 and chromosome 8 isogenic aneuploidy cell model.

| PRJNA1109431 | ENA

Affymetrix SNP array data for Marginal Zone Lymphoma samples

Project description:Marginal zone B-cell lymphomas (MZL) have been divided into three distinct subtypes (extranodal MZL of MALT type, nodal MZL; splenic MZL). Nevertheless, the relationship between them is still unclear. We performed a comprehensive analysis of genomic DNA copy number changes in a very large series of MZL cases with the aim of addressing this question. Samples from 218 MZL patients (25 nodal, 57 MALT, 134 splenic and two not better specified MZL) were analyzed with the Affymetrix Human Mapping 250K SNP arrays, and the data combined with matched gene expression in 33/218 cases. MALT lymphoma presented significantly more frequently gains at 3p, 6p, 18p and del(6q23) (TNFAIP3/A20), whilst splenic MZL was associated with del(7q31), del(8p). Nodal MZL did not show statistically significant differences when compared with MALT lymphoma while lacked the splenic MZL-related 7q losses. Gains of 3q and 18q gains were common to all three subtypes. Del(8p) was often present together with del(17p) (TP53). While del(17p) did not determine a worse outcome and del(8p) was only of borderline significance, the presence of both deletions had a highly significant negative impact on the outcome of splenic MZL.

2011-02-01 | GSE24881 | GEO

Aneuploidy tolerance caused by BRG1 loss allows gain of chromosome 18 and improved fitness

Project description:Aneuploidy results in decreased cellular fitness in many different species and model systems. However, aneuploidy is commonly found in cancer cells and often correlates with aggressive growth and poor prognosis, suggesting that the impact of aneuploidy on cellular fitness is context dependent. The BRG1 (SMARCA4) subunit of the SWI/SNF chromatin remodelling complex is a tumour suppressor that is frequently lost in cancer cells. Here, we used a chromosomally stable cell line to test the effect of BRG1 loss on the evolution of aneuploidy. We find that BRG1 deletion leads to an initial loss of fitness in this cell line that improves over time. The improved fitness correlates with a gain of extra copies of chromosome 18. Notably, changes in pathways that are known to promote tolerance to aneuploidy are evident immediately upon loss of BRG1, providing an environment where karyotype changes associated with a fitness advantage can be explored. At least in some genetic backgrounds, therefore, loss of the SWI/SNF complex can contribute to tumourigenesis through tolerance of aneuploidy.

2022-03-23 | PXD014954 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data